SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Propensity Score-Matched Cohort Study Comparing Adherence and Persistence with Specific Reference to Cardiovascular Disease
- DOI
- 10.3390/ph19101607
- Published
- 2026-10-10
- Container
- Pharmaceuticals
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/ph19101607,
title = {SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Propensity Score-Matched Cohort Study Comparing Adherence and Persistence with Specific Reference to Cardiovascular Disease},
author = {M. Asunción González-González and M. Aránzazu Pedrosa-Naudín and Diego Fernández-Lázaro and Isabel Díaz Planelles and F. Javier Álvarez and Eduardo Gutiérrez-Abejón},
year = {2026},
journal = {Pharmaceuticals},
doi = {10.3390/ph19101607},
url = {https://doi.org/10.3390/ph19101607}
}RIS
TY - JOUR TI - SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Propensity Score-Matched Cohort Study Comparing Adherence and Persistence with Specific Reference to Cardiovascular Disease AU - M. Asunción González-González AU - M. Aránzazu Pedrosa-Naudín AU - Diego Fernández-Lázaro AU - Isabel Díaz Planelles AU - F. Javier Álvarez AU - Eduardo Gutiérrez-Abejón PY - 2026 JO - Pharmaceuticals DO - 10.3390/ph19101607 UR - https://doi.org/10.3390/ph19101607 ER -
APA
González-González, M. A., Pedrosa-Naudín, M. A., Fernández-Lázaro, D., Planelles, I. D., Álvarez, F. J., & Gutiérrez-Abejón, E. (2026). SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Propensity Score-Matched Cohort Study Comparing Adherence and Persistence with Specific Reference to Cardiovascular Disease. Pharmaceuticals. https://doi.org/10.3390/ph19101607
Source records
- crossref · retrieved 2026-11-08T02:44:18.441Z